Literature DB >> 7416620

Platelet consumption and sequestration in severe acute respiratory failure.

R C Schneider, W M Zapol, A C Carvalho.   

Abstract

To evaulate alterations in platelek kinetics and organ sequestration patterns during acute lung injury, we studied the fate of autologous radiolabeled platelets in 15 patients with severe acute respiratory failure (ARF) of diverse etiology. Thrombocytopenia (< 100,000 platelets/microliters) occurred in 10 patients. Platelet lifespan was reduced (2.30 +/- 0.39 days; mean +/- SEM) compared with normal volunteers (6.29 +/- 0.69; p < 0.01). Platelet turnover rate during ARF (251,100 +/- 90,000 platelets/microliters x day) was twice normal and never below the normal range. Platelet sequestration, determined by surface scintillation counting, occurred in the lungs, liver, and spleen. Although our measurements in patients with severe ARF did not determine whether platelets cause or exacerbate acute lung disease, the increased platelet consumption and pulmonary sequestration we detected suggests that platelets are directly involved in the pathophysiology of acute lung injury.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7416620     DOI: 10.1164/arrd.1980.122.3.445

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  22 in total

Review 1.  Amicus or adversary: platelets in lung biology, acute injury, and inflammation.

Authors:  Fernando A Bozza; Amrapali M Shah; Andrew S Weyrich; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

2.  Management of injury due to smoke inhalation.

Authors:  J Brown
Journal:  J R Soc Med       Date:  1982       Impact factor: 5.344

Review 3.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

4.  Contact phase of blood coagulation in cardiogenic pulmonary oedema (CPO) and adult respiratory distress syndrome (ARDS).

Authors:  C Herrera; F Velasco; A Guerrero; R Guerrero; F Alvarez; A Torres
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

5.  Incidence of pulmonary thromboembolism, infarction and haemorrhage in disseminated intravascular coagulation: a necroscopic analysis.

Authors:  Y Katsumura; K Ohtsubo
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

Review 6.  Primary pulmonary hypertension.

Authors:  S G Haworth
Journal:  Br Heart J       Date:  1983-06

7.  Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*.

Authors:  Mark R Looney; Nareg Roubinian; Ognjen Gajic; Michael A Gropper; Rolf D Hubmayr; Clifford A Lowell; Peter Bacchetti; Gregory Wilson; Monique Koenigsberg; Deanna C Lee; Ping Wu; Barbara Grimes; Philip J Norris; Edward L Murphy; Manish J Gandhi; Jeffrey L Winters; David C Mair; Randy M Schuller; Nora V Hirschler; Rosa Sanchez Rosen; Michael A Matthay; Pearl Toy
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

8.  Pentoxifylline attenuates acute lung injury induced by microemboli.

Authors:  C Y Shen; K Hsu; D Wang; H C Yan
Journal:  Experientia       Date:  1995-09-29

9.  The pulmonary vascular lesions of the adult respiratory distress syndrome.

Authors:  J F Tomashefski; P Davies; C Boggis; R Greene; W M Zapol; L M Reid
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

10.  Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.

Authors:  J E Heffner; S A Shoemaker; E M Canham; M Patel; I F McMurtry; H G Morris; J E Repine
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.